By Ryan Davis ( October 3, 2017, 10:10 PM EDT) -- A Johnson & Johnson subsidiary urged the Federal Circuit on Tuesday to reverse a decision invalidating a patent on its blockbuster autoimmune disease drug Remicade for double-patenting, saying the finding conflicts with a 1994 law changing the length of patent terms....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.